SEC Form 4 · accession 0001209191-18-022932
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Van Nostrand
Director
Period of report
Mar 30, 2018
Accepted (ET)
Apr 3, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2018 | A | 237 | $21.05 | A | 3,893 | D |
Table II — derivative securities
No Table II lines on this filing.